Asset Details
Do you wish to reserve the book?
Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness
Do you wish to request the book?
Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Epithelial dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness
2015
Overview
Background
Gastric dysplasia is classified as adenomatous/type I (intestinal phenotype) and foveolar or pyloric/type II (gastric phenotype) according to morphological (architectural and cytological) features. The immunophenotypic classification of dysplasia, based on the expression of the mucins, CD10 and CDX2, recognizes the following immunophenotypes: intestinal (MUC2, CD10, and CDX2); gastric (MUC5AC and/or MUC6, absence of CD10, and absent or low expression of CDX2); hybrid (gastric and intestinal markers); and null.
Methods
Sixty-six cases of nonpolypoid epithelial dysplasia of the stomach were classified according to morphological features (histotype and grade) and immunophenotype. Immunohistochemical staining was performed with antibodies against MUC2, MUC5AC, MUC6, CD10, CDX2, chromogranin, synaptophysin, Ki-67, and TP53. HER2 alterations were analyzed by immunohistochemistry and silver-enhanced in situ hybridization.
Results
By conventional histology, dysplasia was classified as adenomatous/intestinal (
n
= 42; 64 %) and foveolar or pyloric/gastric (
n
= 24; 36 %) and graded as low grade (
n
= 37; 56 %) or high grade (
n
= 29; 44 %). Immunophenotypic classification showed intestinal (
n
= 22; 33.3 %), gastric (
n
= 25; 37.9 %), hybrid (
n
= 17; 25.8 %), or null (
n
= 2; 3.0 %) phenotypes. In 20 cases a coexistent intramucosal carcinoma was identified. The intestinal immunophenotype was shown to be significantly associated with low-grade dysplasia (
p
= 0.001), high expression of CDX2 (
p
= 0.015), TP53 (
p
= 0.034), synaptophysin (
p
= 0.003), and chromogranin (
p
< 0.0001); the gastric immunophenotype was significantly associated with high-grade dysplasia (
p
= 0.001), high Ki-67 proliferative index (
p
= 0.05), and coexistence of intramucosal carcinoma (
p
= 0.013).
HER2
amplification was observed in 3 cases, typed as gastric or hybrid.
Conclusions
Epithelial nonpolypoid dysplasia of the stomach with gastric immunophenotype shows features of biological aggressiveness and may represent the putative precursor lesion in a pathway of gastric carcinogenesis originated de novo from the native gastric mucosa, leading to gastric-type adenocarcinoma.
Publisher
Springer Japan,Springer Nature B.V
Subject
